Search

Search Constraints

You searched for: Author/Creator Nordio, Francesco

Search Results

11. Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF–TIMI 48. Issue 2 (1st March 2019)

12. Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF–TIMI 48. Issue 2 (March 2019)

13. Effects of metal-rich air particles on DNA methylation and on coagulation function among foundry workers in Italy. (19th October 2011)

14. Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial. Issue 3 (5th November 2019)

15. Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF‐TIMI 48. (28th June 2016)

16. Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial. Issue 5 (20th May 2016)

17. Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial. Issue 5 (May 2016)

18. Extracellular histones affect blood coagulation in subjects exposed to metal-rich air particles. (19th October 2011)

19. Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis In Myocardial Infarction). Issue 5 (May 2018)

20. Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials. Issue 9984 (6th June 2015)